Legal & General Group
CELL

Legal & General Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Legal & General Group’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,038
Closed -$7K – 3570
2023
Q1 		$7K Hold
6,038
– – ﹤0.01% 3258
2022
Q4 		$16.2K Buy
6,038
+1,326
+28% +$3.5K ﹤0.01% 3194
2022
Q3 		$13K Sell
4,712
-42,063
-90% -$179K ﹤0.01% 3304
2022
Q2 		$232K Buy
46,775
+20,725
+80% +$109K ﹤0.01% 2577
2022
Q1 		$186K Buy
26,050
+105
+0.4% +$869 ﹤0.01% 2698
2021
Q4 		$471K Buy
25,945
+78
+0.3% +$1.68K ﹤0.01% 2430
2021
Q3 		$506K Buy
25,867
+35
+0.1% +$1.33K ﹤0.01% 2406
2021
Q2 		$1.16M Buy
25,832
+12,240
+90% +$567K ﹤0.01% 2173
2021
Q1 		$682K Buy
13,592
+6,793
+100% +$463K ﹤0.01% 2255
2020
Q4 		$607K Sell
6,799
-4,406
-39% -$371K ﹤0.01% 2219
2020
Q3 		$856K Buy
+11,205
New +$712K ﹤0.01% 2071

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's CELL Position: Q2 2023 in Review

Legal & General Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 6,038 shares — an estimated $7K sold.

Legal & General Group first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $1.16M in Q2 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Legal & General Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 6,038 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $7K.
  • Legal & General Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Legal & General Group's PhenomeX Inc. Common Stock position peaked at $1.16M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.